This is the recording of the regular press briefing of European Medicines Agency on COVID-19 vaccines and therapeutics that took place on 28 May 2021.

00:00 Introduction
01:47 Update on recent developments (as of 28.05.2021) by Dr. Cavaleri
09:13 Global access to COVID-19 vaccines
11:12 Side effects of Comirnaty on children/adolescents
12:54 COVID-19 vaccines for adolescents
14:32 Side effects like TTS after COVID-19 vaccines
15:28 Inflammatory heart disease in kids
18:11 Pharmacovigilance and size of clinical trials
19:31 Mix and match approach of different vaccines
23:21 Doses of vaccine for children
25:08 Total numbers of TTS cases in EU
28:10 Number of cases of myocarditis/pericarditis
30:20 Update on Curevac rolling review
31:33 Origins of COVID-19
33:38 Use of second dose of Astrazeneca and TTS cases
34:53 Vaccination of adolescents
36:55 Wrap-up

EMA Speakers:
Marco Cavaleri, Head of Biological Health Threats and Vaccines Strategy
Fergus Sweeney, Head of Clinical Studies and Manufacturing Task Force
Georgy Genov, Head of Pharmacovigilance

EMA Moderator:
Marie-Agnes Heine, Head of Communication

#EMAPresser #COVID19

свернуть